ArticleFrontiers in neurology
Differential diagnosis between NMOSD and MS: a retrospective study based on clinical and imaging features.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Anti-nuclear antibodies in patients with suspicion of neuromyelitis optica spectrum disorder: Frequency and significance.Pakistan journal of medical sciences · 2026Article
- Neuroimmunological overlap syndromes in optic neuritis, myelitis, and connective tissue diseases.Frontiers in neurologyReview
- The quality of life in Ecuadorian patients with multiple sclerosis and neuromyelitis optica spectrum disorder and their association with anxiety, depression, fatigue, and disability.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neuromyelitis optica spectrum disorders (NMOSD) and multiple sclerosis (MS) are both inflammatory demyelinating diseases of the central nervous system, sharing many similarities in clinical manifestations. However, they differ significantly in terms of etiology, pathological mechanisms, treatment, and prognosis. Since early clinical differentiation can be challenging, achieving an accurate diagnosis at the initial stage of disease onset is particularly critical. Therefore, a thorough analysis of patients' clinical characteristics is of great importance in assisting clinicians with early diagnosis and treatment, ultimately contributing to improved patient outcomes. Methods: Clinical data were collected for patients who were first diagnosed with NMOSD or MS at the General Hospital and the Cardiovascular and Cerebrovascular Hospital of Ningxia Medical University between January 2018 and January 2022. Collected information included demographic data, past medical history, initial clinical symptoms, physical examination findings, laboratory tests, imaging studies, and three types of evoked potentials. Patients were followed up for relapse during remission, presence of residual symptoms, medication use, and scores on the Extended Disability Status Scale (EDSS). The clinical characteristics of the two diseases were summarized and the results subjected to statistical analysis. Results: This study conducted a comparative analysis across multiple indicators, comprehensively revealing significant differences in the clinical characteristics of NMOSD and MS. The results showed that the proportion of female patients was significantly higher in the NMOSD group (86.2%) compared with the MS group (69.0%), with a statistically significant difference ( Conclusion: Although NMOSD and MS share many similarities in clinical symptoms, they differ substantially in their fundamental characteristics, as reflected in demographic features, clinical manifestations, laboratory and imaging findings, as well as prognosis. Compared with MS, NMOSD patients are typically older at disease onset, have a higher proportion of females, and experience more frequent relapses and greater disability. In terms of imaging, MS lesions are predominantly distributed in the brain, whereas NMOSD mainly involves the optic nerve and spinal cord. Therefore, early differentiation between the two diseases in clinical practice is essential for developing targeted treatment strategies and ultimately improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.